
Aprea Therapeutics and Capricor Therapeutics Stocks Surge
Aprea Therapeutics stock recorded a second consecutive surge, jumping another 22%, while Capricor Therapeutics also saw its stock surge following an upgrade from Oppenheimer. These movements indicate positive investor sentiment for both pharmaceutical companies.
The Story
Analyzing sources…



